Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)

Nav

General Info

Geography

Australia (AUS)

Time period covered

01/1996 - 12/1999

Data type

Scientific literature

Keywords

Ischemic heart disease, Ischemic stroke

Citation

Authors

Knopp RH, d’Emden M, Smilde JG, Pocock SJ

Journal

Diabetes Care

Volume

Issue

Pages

1478–85

Publication year

2006

Suggested citation

Knopp RH, d’Emden M, Smilde JG, Pocock SJ. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). Diabetes Care. 2006; 29(7): 1478–85.

GHDx Entry last modified on: Oct 9, 2019

Header sites

Search form

Main menu

Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)

Nav